1-3 of 3
John Slattery
Close
Sort by
Journal Articles

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Clinical Trials & Observations
Michael B. Maris, Dietger Niederwieser, Brenda M. Sandmaier, Barry Storer, Monic Stuart, David Maloney, Effie Petersdorf, Peter McSweeney, Michael Pulsipher, Ann Woolfrey, Thomas Chauncey, Ed Agura, Shelly Heimfeld, John Slattery, Ute Hegenbart, Claudio Anasetti, Karl Blume, Rainer Storb
Journal: Blood
Blood (2003) 102 (6): 2021–2030.
https://doi.org/10.1182/blood-2003-02-0482
Published: 2003
Journal Articles

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

Clinical Trials & Observations
Jerald P. Radich, Ted Gooley, William Bensinger, Thomas Chauncey, Reginald Clift, Mary Flowers, Paul Martin, John Slattery, Debbie Sultan, Frederick R. Appelbaum
Journal: Blood
Blood (2003) 102 (1): 31–35.
https://doi.org/10.1182/blood-2002-08-2619
Published: 2003
Journal Articles

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

Clinical Trials & Observations
Paul A. Carpenter, Frederick R. Appelbaum, Lawrence Corey, H. Joachim Deeg, Kris Doney, Theodore Gooley, James Krueger, Paul Martin, Sandra Pavlovic, Jean Sanders, John Slattery, Daniel Levitt, Rainer Storb, Ann Woolfrey, Claudio Anasetti
Journal: Blood
Blood (2002) 99 (8): 2712–2719.
https://doi.org/10.1182/blood.V99.8.2712
Published: 2002